Gwendolyn Binder
CIK: 0001791742
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 11, 2026TIL
Instil Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
6.5K shares- - Mar 2, 2026CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
225K shares- - Jan 21, 2026CABA
Cabaletta Bio, Inc.
Purchase(P)Direct11.3K shares at avg. $2.19$25K - May 28, 2025TIL
Instil Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
6.5K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
29.9K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
125K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
125K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
160K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
160K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
176K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
176K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
130K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
130K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
66.7K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
66.7K shares- - May 19, 2025CABA
Cabaletta Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
29.9K shares- - Mar 3, 2025CABA
Cabaletta Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
145K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  TIL Instil Bio, Inc. | Award(A) Stock Option (Right to Buy) | 6,500 | - | - | Direct |
| Mar 2, 2026 |  CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 225,000 | - | - | Direct |
| Jan 21, 2026 | CABA Cabaletta Bio, Inc. | Purchase(P) | 11,312 | $2.19 | $24,763 | Direct |
| May 28, 2025 | TIL Instil Bio, Inc. | Award(A) Stock Option (Right to Buy) | 6,500 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 29,908 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 160,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 160,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 176,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 176,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 130,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 130,000 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 66,667 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 66,667 | - | - | Direct |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 29,908 | - | - | Direct |
| Mar 3, 2025 | CABA Cabaletta Bio, Inc. | Award(A) Stock Option (Right to Buy) | 145,000 | - | - | Direct |
1-17 of 17 transactions
About Binder Gwendolyn
Binder Gwendolyn (SEC CIK 0001791742) files insider reports with the SEC as Director of Instil Bio, Inc. (TIL) and President, Science & Tech. of Cabaletta Bio, Inc. (CABA).
Signal8 holds 6 ownership filings by Binder Gwendolyn, all Form 4s, filed between Mar 4, 2025 and Jun 12, 2026. Those filings report 17 transactions, from Mar 3, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Binder Gwendolyn's filings is in DALLAS, TX.
Recent filings by Binder Gwendolyn
- Jun 11, 2026: Grant or award of TIL derivative securities (Form 4, code A).
- Mar 2, 2026: Grant or award of CABA derivative securities (Form 4, code A).
- Jan 21, 2026: Open-market purchase of CABA shares (Form 4, code P).
- May 28, 2025: Grant or award of TIL derivative securities (Form 4, code A).
- May 19, 2025: Grant or award of CABA derivative securities (Form 4, code A).
Other insiders filing for Instil Bio, Inc. (TIL)
- McGaughy R Kent Jr, Director
- Matcham George, Director
- Gibson Neil W, Director
- Laumas Sandeep, CFO and CBO
- Crouch Bronson, CEO and Chairman